UNSPSC 51284102: Cefdaloxime

This classification denotes a cephalosporin antibiotic with the molecular formula C14H15N5O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6856HDT30F, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-oxime but generally known as cefdaloxime, which bears US NIH Compound Identifier 9571072.

UNSPSC 51284102 Cefdaloxime is a Commodity code that represents a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows minimal direct alignment with the code's nominal scope. The Illinois Department of Public Health and Seminole County, Florida have posted or awarded contracts tagged under pharmaceutical procurement codes, but neither solicitation explicitly names cefdaloxime as a procured item. The Illinois award (Solicitation 26482DPHPREPDB53392, completed August 28, 2026) supplied doxycycline hyclate and ciprofloxacin hydrochloride tablets through a piggyback arrangement with the MMCAP Infuse consortium awarded to Chartwell Rx LLC for $2,999,999.11 over three years; the Seminole County IFB (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) sought naloxone and drug deactivation systems for community health initiatives. Both procurements reflect state and local health departments using cooperative purchasing vehicles and competitive bidding to source pharmaceutical and medical products, but the specific antibiotic cefdaloxime does not appear in either opportunity.

The code shows little relevant recent activity. State and local governments appear to source antibiotics and other pharmaceuticals through piggyback contracts with established pharmaceutical distributors and group purchasing consortia rather than through direct solicitations for individual drug products. Illinois Department of Public Health and Seminole County, Florida represent the recent activity captured, with procurement concentrated in health and community services departments. No open solicitations specifically targeting cefdaloxime are evident in the recent opportunity block, and the mismatch between the code's nominal scope and the actual pharmaceutical products being procured suggests that state and local agencies may be tagging pharmaceutical purchases with broader or misaligned UNSPSC codes rather than commodity-level antibiotics codes.